Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to unlock diabetes mysteries in kazakh adults

NCT ID NCT07522502

Knowledge-focused Sponsor: West Kazakhstan Marat Ospanov Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 11, 2026 · Updated 3 times

Summary

This completed study in Kazakhstan looked at 240 adults recently diagnosed with diabetes. Researchers measured blood sugar, insulin resistance, and immune markers to understand how different forms of diabetes develop. The goal is to help doctors diagnose and treat adult-onset diabetes more accurately.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better distinguish between types of adult-onset diabetes and tailor treatment more precisely.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly lead to new therapies. Results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

240 people

The number who actually took part.

Started

May 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with newly diagnosed diabetes recruited from primary health care settings in the Kazakh population. Participants were assessed at the time of diagnosis using clinical, metabolic, and immunological parameters.

Ages

25 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 25 years and older * Kazakh population with newly diagnosed diabetes mellitus * Diagnosis established in routine clinical practice * No prior insulin therapy at the time of enrollment * No prior use of glucose-lowering therapy beyond initial management * Ability and willingness to provide informed consent Exclusion Criteria: * Clinical features suggestive of classical type 1 diabetes at presentation * History of long-term insulin therapy prior to enrollment * Severe acute illness or infection at the time of assessment * Pregnancy * Incomplete clinical or laboratory data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autoimmune diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Inflammation Insulin Resistance type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autoimmune diabetes Diabetes mellitus type 2

Contacts and locations

Locations

  • West Kazakhstan Marat Ospanov Medical University

    Aktobe, 030019, Kazakhstan

More trials for these conditions

Other studies related to the condition(s) this trial covers.